
Talisker Announces Listing of Warrants on TSX
The Warrants were previously issued in connection with the brokered financing completed on May 5, 2025. Each Warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of C$0.75 per share until May 5, 2028, in accordance with the terms of the warrant indenture dated May 5, 2025, which is available under the Company's profile at
www.sedarplus.ca
.
For further information, please contact:
Terry Harbort
President and CEO
terry.harbort@taliskerresources.com
+1 416 357 0227
About Talisker Resources Ltd.
Talisker (taliskerresources.com) is a junior resource company involved in the exploration and development of gold projects in British Columbia, Canada. Talisker's flagship asset is the high-grade, fully permitted Bralorne Gold Project where the Company is currently transitioning into underground production at the Mustang Mine. Talisker projects also include the Ladner Gold Project, an advanced stage project with significant exploration potential from an historical high-grade producing gold mine and the Spences Bridge Project where the Company has a significant landholding in the emerging Spences Bridge Gold Belt, and several other early-stage Greenfields projects.
Caution Regarding Forward Looking Statements
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words 'could', 'intend', 'expect', 'believe', 'will', 'projected', 'estimated' and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Talisker's current belief or assumptions as to the outcome and timing of such future events. In particular, this press release contains forward-looking information relating to, among other things, the listing of the Warrants on the TSX. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to Talisker. Although such statements are based on reasonable assumptions of Talisker's management, there can be no assurance that any conclusions or forecasts will prove to be accurate. The forward-looking information contained in this release is made as of the date hereof, and Talisker is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Integer Appoints Michael Coyle to Board of Directors
~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ~ PLANO, Texas, July 10, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical device industry to Integer and joins the Board as a member of the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee. He most recently served as president and CEO of iRhythm Technologies, a digital healthcare company. Before that, he was executive vice president and group president of Medtronic's cardio and vascular group and held leadership roles at St. Jude Medical and Eli Lilly earlier in his career. Coyle is currently a director on the Haemonetics Corporation and BaroPace boards and previously held positions on the boards of VNUS Medical Technologies, Inc. and Volcano Corporation. He earned a master's degree in business administration from the Wharton School of Business, University of Pennsylvania, and a bachelor's degree from Case Western Reserve University. He additionally holds six U.S. patents related to cardiovascular medical device products and technologies. 'Integer's Board regularly evaluates its composition to ensure it encompasses the appropriate skills, background and perspectives necessary to drive growth for Integer's shareholders,' said Pamela Bailey, Integer Board Chair. 'We are pleased to welcome Michael Coyle, whose extensive medical device industry experience and proven leadership in global business and technology will contribute significantly to our strategic initiatives and culture.' 'The executive leadership team and I look forward to working with Michael as we execute our strategy to deliver sustained outperformance,' said Joseph Dziedzic, Integer president and CEO. 'We are confident Michael's expertise will contribute to Integer's contract development and manufacturing outsourcing strategy, furthering our position as our customers' partner of choice for innovative medical technologies and services as we realize our vision to enhance the lives of patients worldwide.'About Integer®Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at Investor Relations: Media Relations: Kristen Stewart Kelly Butler 551.337.3973 469.731.6617


Business Wire
34 minutes ago
- Business Wire
FTNT Investors Have Opportunity to Join Fortinet, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fortinet, Inc. ('Fortinet' or 'the Company') (NASDAQ: FTNT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Fortinet reported its Q2 financial results on August 6, 2025. Investor's Business Daily quotes William Blair analyst Jonathan Ho as stating, 'Investors were left confused by the company's formal statement that 40% to 50% of its accelerated firewall refresh (estimated to be a $450 million, 650,000 unit opportunity) was now completed. This is driving confusion about why Fortinet is not seeing stronger product revenue growth and billings materialize." Based on this news, shares of Fortinet opened down 25.3% on August 7, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Yahoo
an hour ago
- Yahoo
TSX flat as investors assess earnings and US tariff effects
(Reuters) - Canada's benchmark index was little changed on Thursday, with investors assessing corporate earnings while weighing the impact of U.S. tariff implementation. At 9:31 a.m. ET (1331 GMT), the Toronto Stock Exchange's S&P/TSX composite index was at 27,935.73 points after briefly surpassing Wednesday's record highs. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data